Queerty on MSN15d
A once-a-year PrEP injection? The results of the first clinical trial look promisingPharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The company revealed its results at this week’s Conference on Retroviruses and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback